EP1343813A4 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: EP1343813A4
Authority: EP; European Patent Office
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2000-12-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP01991347A

Other languages

German (de)

French (fr)

Other versions

EP1343813A1 (en

Inventor

Pankaj Agarwal

Marian Birkeland

John P Cogswell

Karen F Kabnick

Ying-Ta Lai

Shelby A Martensen

Safia K Rizvi

Randall F Smith

Jay C Strum

Qing Xie

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Ltd

Glaxo Group Ltd

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Ltd

Glaxo Group Ltd

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-19

Filing date

2001-12-17

Publication date

2004-11-17

2001-12-17 Application filed by SmithKline Beecham Ltd, Glaxo Group Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd

2003-09-17 Publication of EP1343813A1 publication Critical patent/EP1343813A1/en

2004-11-17 Publication of EP1343813A4 publication Critical patent/EP1343813A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Cardiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP01991347A 2000-12-19 2001-12-17 Novel compounds Withdrawn EP1343813A4 (en)

Applications Claiming Priority (17)

Application Number	Priority Date	Filing Date	Title
US25671000P	2000-12-19	2000-12-19
US256710P		2000-12-19
US25704800P	2000-12-20	2000-12-20
US257048P		2000-12-20
US26048201P	2001-01-09	2001-01-09
US260482P		2001-01-09
US26492201P	2001-01-30	2001-01-30
US264922P		2001-01-30
US26679701P	2001-02-06	2001-02-06
US266797P		2001-02-06
US27698801P	2001-03-19	2001-03-19
US276988P		2001-03-19
US28153501P	2001-04-04	2001-04-04
US281535P		2001-04-04
US28962201P	2001-05-08	2001-05-08
US289622P		2001-05-08
PCT/US2001/049232 WO2002050105A1 (en)	2000-12-19	2001-12-17	Novel compounds

Publications (2)

Publication Number	Publication Date
EP1343813A1 EP1343813A1 (en)	2003-09-17
EP1343813A4 true EP1343813A4 (en)	2004-11-17

Family

ID=27575289

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01991347A Withdrawn EP1343813A4 (en)	2000-12-19	2001-12-17	Novel compounds

Country Status (4)

Country	Link
EP (1)	EP1343813A4 (en)
JP (1)	JP2004531214A (en)
AU (1)	AU2002231077A1 (en)
WO (1)	WO2002050105A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001239765A1 (en) *	2000-02-14	2001-08-27	Smith Kline Beecham Corporation	Novel compounds
JP2003533982A (en) *	2000-03-24	2003-11-18	スミスクライン・ビーチャム・コーポレイション	New compound
US20020111302A1 (en) *	2000-11-30	2002-08-15	Y. Tom Tang	Novel nucleic acids and polypeptides
EP1348023A2 (en) *	2000-12-18	2003-10-01	Millennium Pharmaceuticals, Inc.	53010, a human carboxylesterase family member and uses thereof
AU2002324058A1 (en) *	2001-08-21	2003-03-10	Bayer Healthcare Ag	Regulation of human g protein-couple receptor kinase
US20050064544A1 (en) *	2001-10-24	2005-03-24	Rosana Kapeller-Libermann	69583 and 85924 Novel human protein kinase family members and uses therefor
WO2003046006A1 (en) *	2001-11-27	2003-06-05	Bayer Healthcare Ag	Polynucleotides encoding nexin-related serine protease inhibitor
FR2837492B1 (en) *	2002-03-21	2007-07-20	Commissariat Energie Atomique	APICAL IODE TRANSPORTER AND ITS APPLICATIONS
EP1562969A4 (en)	2002-03-28	2006-07-05	Bristol Myers Squibb Co	Novel human cell surface protein with immunoglobulin folds, bgs-19
CA2488382A1 (en)	2002-06-05	2003-12-18	Case Western Reserve University	Methods and compositions for detecting cancers
AU2003243151A1 (en)	2002-08-16	2004-03-03	Agensys, Inc.	Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2005095637A1 (en) *	2004-03-02	2005-10-13	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 beta (mlk4 beta)
WO2005103240A1 (en) *	2004-04-24	2005-11-03	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 1 (csnk1d iso 1)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999001020A2 (en) *	1997-07-01	1999-01-14	Human Genome Sciences, Inc.	19 human secreted proteins
WO1999058565A1 (en) *	1998-05-08	1999-11-18	Karolinska Innovations Ab	Cystatin-related protein
EP0976764A1 (en) *	1997-04-01	2000-02-02	Chugai Research Institute for Molecular Medicine Inc.	Novel membrane-secreted protein
WO2000031264A2 (en) *	1998-11-20	2000-06-02	Zymogenetics, Inc.	Testis-specific cystatin-like protein cystatin t
WO2001094388A2 (en) *	2000-06-05	2001-12-13	Zymogenetics, Inc.	Zcys6: a member of the cystatin superfamily

2001
- 2001-12-17 EP EP01991347A patent/EP1343813A4/en not_active Withdrawn
- 2001-12-17 AU AU2002231077A patent/AU2002231077A1/en not_active Abandoned
- 2001-12-17 JP JP2002551998A patent/JP2004531214A/en active Pending
- 2001-12-17 WO PCT/US2001/049232 patent/WO2002050105A1/en not_active Application Discontinuation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0976764A1 (en) *	1997-04-01	2000-02-02	Chugai Research Institute for Molecular Medicine Inc.	Novel membrane-secreted protein
WO1999001020A2 (en) *	1997-07-01	1999-01-14	Human Genome Sciences, Inc.	19 human secreted proteins
WO1999058565A1 (en) *	1998-05-08	1999-11-18	Karolinska Innovations Ab	Cystatin-related protein
WO2000031264A2 (en) *	1998-11-20	2000-06-02	Zymogenetics, Inc.	Testis-specific cystatin-like protein cystatin t
WO2001094388A2 (en) *	2000-06-05	2001-12-13	Zymogenetics, Inc.	Zcys6: a member of the cystatin superfamily

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO0250105A1 *
TOEHOENEN V ET AL: "TESTATIN: A CYSTATIN-RELATED GENE EXPRESSED DURING EARLY TESTIS DEVELOPMENT", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 95, January 1998 (1998-01-01), pages 14208 - 14213, XP000857715, ISSN: 0027-8424 *

Also Published As

Publication number	Publication date
AU2002231077A1 (en)	2002-07-01
JP2004531214A (en)	2004-10-14
WO2002050105A1 (en)	2002-06-27
EP1343813A1 (en)	2003-09-17

Publication	Publication Date	Title
AU7476301A (en)	2002-01-02	Novel compounds
EP1276755A4 (en)	2004-03-31	Novel compounds
GB0003019D0 (en)	2000-03-29	Novel compounds
AU9261901A (en)	2002-03-26	Novel compounds
GB0008464D0 (en)	2000-05-24	Novel compounds
EP1255771A4 (en)	2004-09-29	Novel compounds
EP1292617A4 (en)	2005-04-06	Novel compounds
EP1472352A4 (en)	2005-10-12	Novel compounds
EP1343813A4 (en)	2004-11-17	Novel compounds
AU7476401A (en)	2002-01-02	Novel compounds
EP1276866A4 (en)	2005-03-16	Novel compounds
GB0004149D0 (en)	2000-04-12	Novel compounds
EP1299530A4 (en)	2005-03-09	Novel compounds
GB0003636D0 (en)	2000-04-05	Novel compounds
GB0001898D0 (en)	2000-03-22	Novel compounds
GB0002402D0 (en)	2000-03-22	Novel compounds
GB0004196D0 (en)	2000-04-12	Novel compounds
EG22332A (en)	2002-12-31	Novel compounds
GB0002330D0 (en)	2000-03-22	Novel compounds
GB0003103D0 (en)	2000-03-29	Novel compounds
GB0000928D0 (en)	2000-03-08	Novel compounds
GB0004186D0 (en)	2000-04-12	Novel Compounds
GB0001899D0 (en)	2000-03-22	Novel compounds
GB0001936D0 (en)	2000-03-22	Novel compounds
GB0002096D0 (en)	2000-03-22	Novel compounds

Legal Events

Date	Code	Title	Description
2003-08-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-09-17	17P	Request for examination filed	Effective date: 20030606
2003-09-17	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2003-09-17	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2004-08-18	RIC1	Information provided on ipc code assigned before grant	Ipc: 7C 12N 15/86 B Ipc: 7C 12N 15/85 B Ipc: 7C 12N 15/63 B Ipc: 7C 12N 15/00 B Ipc: 7C 12N 1/21 B Ipc: 7C 07K 14/00 B Ipc: 7C 07H 21/04 B Ipc: 7C 07H 21/02 B Ipc: 7C 07K 14/47 A
2004-11-17	A4	Supplementary search report drawn up and despatched	Effective date: 20040929
2006-05-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2006-06-07	18D	Application deemed to be withdrawn	Effective date: 20051206